Mesothelioma News and Research

RSS
Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or have been exposed to high levels of asbestos fibers.
New NCCN patient guide for Waldenström's Macroglobulinemia helps make informed treatment decisions

New NCCN patient guide for Waldenström's Macroglobulinemia helps make informed treatment decisions

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

Global experts meet at IASLC 17th World Conference on Lung Cancer in Vienna

Global experts meet at IASLC 17th World Conference on Lung Cancer in Vienna

D.C. Council passes ‘Death with Dignity Act’ by a veto-proof 11-2 margin

D.C. Council passes ‘Death with Dignity Act’ by a veto-proof 11-2 margin

Scientists identify genetic mutations in highly aggressive rhabdoid meningiomas

Scientists identify genetic mutations in highly aggressive rhabdoid meningiomas

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Scientists discover new option for treating malignant pleural mesothelioma

Scientists discover new option for treating malignant pleural mesothelioma

NCCN publishes new resources to help patients understand treatment options for stomach cancer

NCCN publishes new resources to help patients understand treatment options for stomach cancer

New NCCN Imaging AUC released for eight new cancers

New NCCN Imaging AUC released for eight new cancers

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Novel combination therapy slows cancer growth in patients with advanced solid tumors

Novel combination therapy slows cancer growth in patients with advanced solid tumors

NCCN educational resources provide insight for patients with Mycosis Fungoides

NCCN educational resources provide insight for patients with Mycosis Fungoides

PD surgery improves quality of life in patients with malignant pleural mesothelioma

PD surgery improves quality of life in patients with malignant pleural mesothelioma

AstraZeneca, MedImmune to provide update on extensive oncology pipeline at ASCO 2016

AstraZeneca, MedImmune to provide update on extensive oncology pipeline at ASCO 2016

NCCN publishes series of patient education materials for Non-Hodgkin's Lymphoma

NCCN publishes series of patient education materials for Non-Hodgkin's Lymphoma

International scientists discuss new treatments for non small cell lung cancer

International scientists discuss new treatments for non small cell lung cancer

New drug shows promise against mesothelioma

New drug shows promise against mesothelioma

ONCOblot test shows promise in early detection of malignant mesothelioma

ONCOblot test shows promise in early detection of malignant mesothelioma

Bevacizumab extends survival of pleural mesothelioma patients

Bevacizumab extends survival of pleural mesothelioma patients

Four unrelated families share identical BAP1 mutation that causes several cancers

Four unrelated families share identical BAP1 mutation that causes several cancers